01515 CR MEDICAL
Closed Add to Porfolio| Key Financial Ratio (Fiscal Year: 12/2024) | |||
| Current | 0.72X | Oper Margin | 8.3% |
|---|---|---|---|
| LT Debt/Equity | 13.6% | Net Margin | 5.7% |
| Total Debt/Equity | 25.7% | Return on Equity | 9.1% |
| Price/Book | 0.83X | Return on Assets | 4.3% |
| (HKD 4.210) | 2024-12 | 2023-12 | 2022-12 | 2021-12 | 2020-12 |
| Net Profit (MHKD) | 601.81 | 284.01 | 298.08 | 511.15 | 368.06 |
|---|---|---|---|---|---|
| Net Profit Growth (%) | +111.9 | -4.7 | -41.7 | +38.9 | -15.8 |
| Earnings Per Share (HKD) | 0.476 | 0.225 | 0.236 | 0.407 | 0.293 |
| Earnings Per Share Growth (%) | +111.9 | -4.9 | -42.0 | +38.9 | -15.9 |
| Dividend Per Share (HKD) | 0.144 | 0.066 | 0.037 | 0.120 | 0.088 |
| P/E* (X) | 8.84 | 18.74 | 17.82 | 10.34 | 14.36 |
| Yield (%) | 3.41 | 1.57 | 0.88 | 2.85 | 2.10 |
| Dividend Share (%) | 30.19 | 29.39 | 15.66 | 29.48 | 30.09 |
| Book NAV (HKD) | 5.096 | 4.940 | 8.220 | 6.085 | 5.588 |
| Auditors' Opinion | Unqualified | Unqualified | Unqualified | Unqualified | Unqualified |
Remarks:
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
1. Unqualified = Not Qualified because the financial statements have been fairly presented in accordance with appropriate accounting standards and companies ordinance.
2. Unqualified # = Not Qualified in respect of fundamental uncertainty because of appropriate disclosures.
3. Qualified = Qualified Opinion in respect of limitation in audit scope and/or disclaimer on view given by financial statements and/or disagreement of accounting treatment and/or adverse opinion.
Last Update Time: 2025-07-22 21:40:20
Latest Result
| (RMBMn) | 2024-12 | 2023-12 | Chg* (%) | 2022-12 |
| Cover Period (mths) | 12 | 12 | NA | 12 |
|---|---|---|---|---|
| Turnover | 9,855 | 10,108 | -2.5 | 7,901 |
| Operating Result | 751.254 | 404.526 | +85.7 | 329.505 |
| Associates | 98.603 | 90.78 | +8.6 | 88.068 |
| Profit Before Taxation | 838.67 | 492.921 | +70.1 | 422.941 |
| Taxation | 166.923 | 165.031 | +1.1 | 94.66 |
| Profit /( Loss) After Taxation | 671.747 | 327.89 | +104.9 | 328.281 |
| Minority Interests | 105.872 | 70.21 | +50.8 | 62.426 |
| Net Profit | 565.875 | 257.68 | +119.6 | 265.855 |
| Earnings Per Share () | 0.4760 | 0.2246 | +111.9 | 0.2362 |
| Dividend Per Share () | 0.1437 | 0.0660 | +117.7 | 0.0370 |
| Announcement Date | 2025-03-25 | 2024-03-19 | NA | 2023-03-28 |
* Annualised
Last Update Time: 2025-07-22 21:40:25
